Steve Jennings/Getty Images/TechCrunch
- 23andMe stock is down over 95% from its peak, cutting its value from $6 billion to $345 million.
- The genetic-testing company is facing financial and strategic challenges, and was hacked last year.
- The startup's backers, including Sequoia Capital, have taken big hits to their investments.
23andMe has gone from a Silicon Valley darling


